Tag: Health Claims

Displaying 1 - 20 of 908 results.

Pages

The Federal Trade Commission testified before the House Energy and Commerce Subcommittee on Consumer Protection and Commerce on legislation to modify the FTC’s authority and address other pressing issues facing the agency.
The Federal Trade Commission charged an online marketer with falsely promising consumers that he could quickly deliver facemasks and other personal protective equipment during the COVID-19 pandemic, then failing to deliver on customers’ orders or offer cancellations or refunds.
No one can top Waylon Jennings’ invitation to Luckenbach, Texas, where people can get “Back to the Basics of Love.” But we can offer the next best thing for business executives, advertising professionals, and attorneys: a virtual invitation to Dallas, Texas, on June 24, 2021, to get...
The medical director of California-based Golden Sunrise Nutraceutical, Inc., agreed to settle Federal Trade Commission charges that he took part in deceptively advertising a $23,000 treatment plan as a scientifically proven way to treat COVID-19. Dr. Stephen Meis will be barred from making similar...
Following a public comment period, the Federal Trade Commission has approved final administrative consent orders against three companies, BASF SE, its subsidiary, BASF Corp.
People facing infertility have a lot to think about in exploring the options available to them. But one thing that shouldn’t be on that list are unapproved products that make questionable claims to “treat” infertility. That’s the warning the FTC and the FDA have sent to companies that...
The Federal Trade Commission has joined the U.S. Food and Drug Administration (FDA) in sending warning letters to five companies that may be making false or unsubstantiated claims that their products can cure, treat, mitigate, or prevent infertility and other reproductive disorders in violation of...
It’s not like the FTC to dive in to a major law enforcement initiative, make a splash, and then leave the pool. If industry members thought December’s Operation CBDeceit was the end of the agency’s interest in deceptive health-related representations for CBD products, they were...
The Federal Trade Commission today announced its latest law enforcement action to halt deceptive health and efficacy claims in the growing market for cannabidiol (CBD) products.
In May 2021, the FTC filed a complaint against Kushly Industries LLC and its CEO, Cody Alt, for allegedly marketing products containing cannabidiol (CBD) using unsubstantiated health and establishment claims. According to the complaint Kushly sold a variety of CBD products to the...
FTC staff sent 30 warning letters to companies, raising concerns about their COVID-related advertising claims. In two notable ways, some of these letters differ from letters we’ve sent to other marketers pitching products advertised to prevent, treat, or cure COVID-19.
The Federal Trade Commission announced that 30 more marketers nationwide have stopped making unsubstantiated claims that their products and therapies can prevent or treat COVID-19, the disease caused by the novel coronavirus. The marketers removed these claims after receiving FTC warning letters...
In testimony today before the Senate Commerce Committee’s Subcommittee on Consumer Protection, Product Safety, and Data Security, the Federal Trade Commission provided an update on its work to protect consumers from scams and frauds related to the COVID-19 pandemic.

Pages